# Project Engage: Oral PrEP Acceptability

> **NCT05458765** · PHASE2 · COMPLETED · sponsor: **Eastern Virginia Medical School** · enrollment: 330 (actual)

## Conditions studied

- Acceptability of Health Care
- Adherence, Medication

## Interventions

- **DRUG:** emtricitabine/tenofovir alafenamide
- **DRUG:** Emtricitabine / Tenofovir Disoproxil Oral Tablet

## Key facts

- **NCT ID:** NCT05458765
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-21
- **Primary completion:** 2023-12-13
- **Final completion:** 2024-07-25
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2024-07-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05458765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05458765, "Project Engage: Oral PrEP Acceptability". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05458765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*